Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „occurred“
Suchtreffer
Begriffe & Kennungen
Adtralza · 4.8 · Conjunctivitis and related events Conjunctivitis occurred more frequently in atopic dermatitis patients who re
Eintrag öffnenAdtralza · 4.8 · Injection site reactions Injection site reactions (including pain and redness) occurred more frequently in pat
Eintrag öffnenAfqlir · 4.8 · Serious ocular adverse reactions in the study eye related to the injection procedure have occurred in less tha
Eintrag öffnenAfqlir · 4.8 · Serious ocular adverse reactions in the study eye related to the injection procedure have occurred in less tha
Eintrag öffnenAhzantive · 4.8 · Serious ocular adverse reactions in the study eye related to the injection procedure have occurred in less tha
Eintrag öffnenAhzantive · 4.8 · Serious ocular adverse reactions in the study eye related to the injection procedure have occurred in less tha
Eintrag öffnenAimovig · 4.8 · Table 1 lists all adverse drug reactions that occurred in Aimovig-treated patients during the 12-week placebo-
Eintrag öffnenAlecensa · 4.8 · Interstitial lung disease (ILD) / pneumonitis Across clinical trials, ILD/pneumonitis occurred in 1.7 % of pat
Eintrag öffnenAlunbrig · 4.8 · Dose reduction for CPK elevation occurred in 10% of patients at the 180 mg regimen (see sections 4.2 and 4.4).
Eintrag öffnenAlunbrig · 4.8 · Dose reduction for elevation of ALT and AST occurred in 0.7% and 1.1% of patients, respectively at the 180 mg
Eintrag öffnenAlunbrig · 4.8 · Dose reduction for elevation of lipase and amylase occurred in 4.7% and 2.9% of patients, respectively at the
Eintrag öffnenAlunbrig · 4.8 · Dose reduction for visual disturbance occurred in two patients (0.7%) at the 180 mg regimen (see sections 4.2
Eintrag öffnenAlunbrig · 4.8 · Sixty one percent of patients experienced hyperglycaemia. Grade 3 hyperglycemia occurred in 6.6% of patients.
Eintrag öffnenAlymsys · 4.8 · Across clinical trials, the following grade 3 and 4 (NCI-CTCAE v.3) laboratory abnormalities occurred in patie
Eintrag öffnenAmgevita · 4.8 · 76 No ALT elevations ≥ 3 × ULN occurred in the phase 3 trial of adalimumab in paediatric patients with plaque
Eintrag öffnenAmgevita · 4.8 · No ALT elevations ≥ 3 X ULN occurred in the phase 3 trial of adalimumab in paediatric patients with plaque pso
Eintrag öffnenAmsparity · 4.8 · No ALT elevations ≥ 3 x ULN occurred in the Phase 3 trial of adalimumab in paediatric patients with plaque pso
Eintrag öffnenAmsparity · 4.8 · No ALT elevations ≥ 3 x ULN occurred in the Phase 3 trial of adalimumab in paediatric patients with plaque pso
Eintrag öffnenAmsparity · 4.8 · No ALT elevations ≥3 x ULN occurred in the Phase 3 trial of adalimumab in paediatric patients with plaque psor
Eintrag öffnenAprovel · 4.8 · Very common: Hyperkalaemia* occurred more often in diabetic patients treated with irbesartan than with placebo
Eintrag öffnen